Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Avacopan bulk supplier for pharma manufacturers

Avacopan 10 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 10 mg

Reference Brands: Tavneos (USA/EU)

Category: Immune Disorder

Avacopan is a Immune Disorder product available as Capsules in strengths 10 mg. It corresponds to the reference brand Tavneos (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Avacopan is a targeted immunomodulatory medicine sold under the brand name Tavneos and is used in the treatment of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. This includes serious autoimmune conditions such as granulomatosis with polyangiitis and microscopic polyangiitis. It is prescribed for adults with severe active disease and is used together with standard background therapy, including glucocorticoids and other immunosuppressive agents.

Avacopan works as a selective complement 5a (C5a) receptor antagonist. By blocking the C5a receptor on neutrophils, it reduces complement-driven inflammation and prevents excessive activation and migration of these immune cells to blood vessel walls. This helps limit vascular inflammation and tissue damage associated with ANCA-associated vasculitis. In addition to its primary mechanism, avacopan also acts as a cytochrome P450 3A4 inhibitor, which is an important consideration for potential drug interactions.

Through its targeted pathway, avacopan provides a steroid-sparing treatment approach and represents an important advancement in the management of severe ANCA-associated vasculitis.

Avacopan — third party manufacturing & bulk supply

Avacopan 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Avacopan is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Avacopan listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Avacopan →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Avacopan is used for the treatment of ANCA-associated vasculitis, including granulomatosis with polyangiitis and microscopic polyangiitis, to help control inflammation and disease activity.

Avacopan is a synthetic small-molecule complement 5a receptor antagonist designed to block C5a-mediated inflammatory signaling.

The trade name of avacopan is Tavneos.

Avacopan (Tavneos) is developed and marketed by ChemoCentryx (now part of Amgen).

The generic name is avacopan.

The brand name is Tavneos.

Avacopan capsules are manufactured in GMP-certified facilities through Amgen and its authorized global manufacturing partners.

Related Products

Etrasimod Arginine

Strength:
2 mg, 4 mg, 6 mg

Form: Tablets

Reference Brands: Velsipity (USA)

View Details
Fostamatinib Disodium

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Tavalisse (USA)

View Details
Deucravacitinib

Strength:
6 mg

Form: Tablet

Reference Brands: Sotyktu (USA/EU)

View Details
Auranofin

Strength:
3 mg

Form: Capsules

Reference Brands: Ridaura (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.